SCHEMBL25328874

SCHEMBL25328874

N#Cc1ccc(N2CCC(c3cc[c]cc3)CC2)cc1Cl

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 17/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25329977 0.86 AR (0.43) AR
SCHEMBL25330105 0.81 AR (0.39) AR
SCHEMBL25329415 0.81 AR (0.42) AR
SCHEMBL24187187 0.80 AR (0.84) AR
SCHEMBL4299688 0.78 AR (0.61) AR
SCHEMBL25330058 0.77 AR (0.50) AR
SCHEMBL10063487 0.76 AR (0.60) AR
SCHEMBL15117196 0.76 AR (0.60) AR
SCHEMBL13651244 0.76 AR (0.72) AR
SCHEMBL13651246 0.76 AR (0.72) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 — — WO disclosed
Send feedback